Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study
-
Published:2024-06
Issue:6
Volume:24
Page:e257-e266
-
ISSN:2152-2650
-
Container-title:Clinical Lymphoma Myeloma and Leukemia
-
language:en
-
Short-container-title:Clinical Lymphoma Myeloma and Leukemia
Author:
Zhang XiaoshuaiORCID, Xu Na, Yang YunfanORCID, Lin Hai, Liu Bingcheng, Du XinORCID, Liu Xiaoli, Liang Rong, Chen Chunyan, Huang Jian, Zhu Huanling, Pan Ling, Wang Xiaodong, Li Guohui, Liu Zhuogang, Zhang Yanqing, Liu Zhenfang, Hu Jianda, Liu Chunshui, Li Fei, Yang Wei, Meng Li, Han Yanqiu, Lin Li'e, Zhao Zhenyu, Tu Chuanqing, Zheng Caifeng, Bai Yanliang, Zhou ZepingORCID, Chen Suning, Qiu Huiying, Yang Lijie, Sun Xiuli, Sun Hui, Zhou LiORCID, Liu Zelin, Wang Danyu, Guo Jianxin, Pang Liping, Zeng Qingshu, Suo Xiaohui, Zhang Weihua, Zheng Yuanjun, Zhang Yanli, Li Weiming, Jiang Qian
Funder
Foundation for Innovative Research Groups of the National Natural Science Foundation of China
|
|